Search results
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance UK· 6 days agoModerna is also evaluating mRNA-1345 in early-stage studies for high-risk adults, as well as...
Adobe Inc. (NASDAQ:ADBE) Q2 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance UK· 2 days agoAdobe Inc. (NASDAQ:ADBE) Q2 2024 Earnings Call Transcript June 13, 2024 Adobe Inc. beats earnings...
Street calls of the week: Upgrade for Shopify; downgrades for AMD, Paramount
Investing.com via Yahoo Finance UK· 16 hours agoThe company’s two primary assets, setrusumab and alvelestat, originate from large pharmaceutical companies (Novartis/NVS and AstraZeneca/AZN, respectively). In the brokerage ...
The seven absolute return funds that have always made money over 3yrs | Trustnet
TrustNet· 6 days agoTargeted absolute return funds aim to give investors the smoothest ride possible, making a positive return while mitigating volatility. First is the £1.7bn Jupiter Merian Global Equity Absolute ...
Study finds how lung cancer mutations may influence treatment response
Euronews via Yahoo News UK· 2 days agoMutations in these proteins are often hallmarks of cancer which is why the team of researchers from...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 6 days agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
Nearing its 52-week low, this growth stock could be the bargain of the year!
Fool.co.uk via Yahoo Finance UK· 7 days agoShares of this US technology giant have fallen from grace in 2024, but is the growth stock now...
London pre-open: Stocks set for lower start after EU elections
ShareCast· 7 days agoStocks in London look primed for a lower start as investors digest the gains made by far right...
London open: Political instability hits stocks early on
ShareCast· 6 days agoUK stocks followed European markets lower on Monday with investor risk appetite dampened by election...
Another Approach To Checkpoint Inhibitors: Targeting Receptors
Forbes· 7 days agoAn alternative to PD-1 targeting cancer therapies, PD-L1 checkpoint inhibitors boost antitumor...